JAPANESE pharmaceutical company Eisai has topped the rankings of pharmaceutical companies listed in the 2025 Global 100 Most Sustainable Corporations in the World (Global 100).
Ranked at 35, Eisai is the highest among global pharmaceutical companies, with Novonesis (49), Novo Nordisk (62) and Sanofi (91) also making the top 100.
Eisai Australia supplies medications in neurology and oncology therapy areas.
The Global 100 global ranking is determined by Canada-based media and investment advisory company, Corporate Knights, and started in 2005.
It evaluates the sustainability of more than 8,300 of the world's major corporations based on various corporate initiatives in areas related to environment, society and governance (ESG).
Eisai rated well on indicators reflecting sustainability targets in executive compensation, enhancing measures to maintain employee health, employee retention rate and environmental conservation initiatives, the company said.
Eisai's stated aim is to "give first thought to patients...and increase the benefits that health care provides to them as well as meet their diversified healthcare needs worldwide".
The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jan 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jan 25
